Amrize (NYSE:AMRZ) Upgraded by DA Davidson to "Hold" Rating

Key Points

• DA Davidson upgraded Amrize to “Hold”, while analysts remain mixed overall; the stock carries a “Moderate Buy” consensus rating and an average price target of $59.87.
• Amrize shares opened at $44.26, near their 52-week low of $43.69 and below the 50-day and 200-day moving averages. The company’s latest quarterly EPS of $0.88 missed the $0.92 consensus estimate, despite $3.49 billion in revenue.
• Insiders showed confidence by purchasing 14,828 shares worth about $697,479 over the past three months, including purchases by the CFO and another insider on August 11.

Amrize (NYSE:AMRZ - Get Free Report) was upgraded by stock analysts at DA Davidson to a "hold" rating in a research note issued to investors on Monday,Zacks.com reports.

AMRZ has been the subject of a number of other reports. Stephens lowered their price objective on Amrize from $65.00 to $54.00 and set an "overweight" rating for the company in a research note on Wednesday, August 12th. Truist Financial restated a "hold" rating and set a $48.00 price target (down from $65.00) on shares of Amrize in a research report on Tuesday, July 7th. Zacks Research cut shares of Amrize from a "hold" rating to a "strong sell" rating in a report on Wednesday, August 19th. Wells Fargo & Company reduced their target price on shares of Amrize from $65.00 to $58.00 and set an "overweight" rating for the company in a research note on Wednesday, July 8th. Finally, Weiss Ratings upgraded shares of Amrize from a "sell (d+)" rating to a "hold (c)" rating in a research report on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Amrize has an average rating of "Moderate Buy" and an average target price of $59.87.

Amrize Stock Performance

Shares of NYSE AMRZ opened at $44.26 on Monday. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. The firm's 50-day moving average price is $50.14 and its two-hundred day moving average price is $54.03. Amrize has a 52-week low of $43.69 and a 52-week high of $65.94. The stock has a market capitalization of $24.48 billion, a P/E ratio of 20.40, a P/E/G ratio of 1.00 and a beta of 0.11.

Amrize (NYSE:AMRZ - Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). The company had revenue of $3.49 billion for the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. As a group, sell-side analysts forecast that Amrize will post 2.74 earnings per share for the current year.

Insider Activity at Amrize

In related news, CFO Baris Oran purchased 3,000 shares of Amrize stock in a transaction dated Tuesday, August 11th. The stock was bought at an average cost of $47.38 per share, with a total value of $142,140.00. Following the purchase, the chief financial officer owned 3,000 shares in the company, valued at approximately $142,140. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Stephen S. Clark acquired 5,260 shares of the firm's stock in a transaction dated Tuesday, August 11th. The stock was bought at an average price of $47.31 per share, with a total value of $248,850.60. Following the completion of the acquisition, the insider directly owned 10,637 shares of the company's stock, valued at approximately $503,236.47. This represents a 97.82% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased 14,828 shares of company stock worth $697,479 in the last three months. Insiders own 0.54% of the company's stock.

Institutional Investors Weigh In On Amrize

Institutional investors have recently added to or reduced their stakes in the company. MCF Advisors LLC acquired a new position in shares of Amrize during the 4th quarter valued at $27,000. Basepoint Wealth LLC bought a new position in Amrize during the fourth quarter valued at about $33,000. Laurel Wealth Advisors LLC bought a new position in Amrize during the fourth quarter valued at about $34,000. Itau Unibanco Holding S.A. boosted its stake in Amrize by 150.0% during the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company's stock valued at $41,000 after buying an additional 450 shares in the last quarter. Finally, US Bancorp DE acquired a new position in Amrize during the third quarter worth about $38,000.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.